Northwind Pharmaceuticals

Northwind Adds Healthcare Executive

 

INDIANAPOLIS – Northwind Pharmaceuticals has announced the hiring of Elizabeth “Betsy” Bigler, MSN, BS, RNC-OB as Vice President of Quality and Administration.

“Betsy is an exciting addition to our leadership team,” said CEO Phillip Berry. “Her strong leadership skills, deep clinical experience, and Lean process improvement expertise bring tremendous value to Northwind and to our clinic customers.”

Bigler joins Northwind from Community Health Network, where she served as Director of Maternity Services. A 2008 graduate from the Purdue School of Nursing, Bigler obtained her Master’s degree from the University of Indianapolis in 2013 and her Six Sigma Blackbelt Certification in 2016. Bigler joins Northwind full time after serving in a consulting role in which her extensive knowledge of leadership, accountability, safety, compliance, and operations has already brought significant improvement.

“Joining Northwind Pharmaceuticals provides me with a wonderful opportunity to serve patients in a new way,” said Bigler. “I am proud to join an organization with a mission to enable enhanced patient access to cost-effective medications, ultimately improving the health of families in our communities.”

Northwind provides diverse pharmaceutical repackaging, fulfillment, and support services to patients, medical providers, and employer groups nationally. Founded in 1981 and based in Indianapolis, Northwind enables medical providers to get prescription drugs to their patients in the clinic, at home, at work, and in care facilities. With a particular focus on self-funded employer groups, Northwind provides money-saving drug management and delivery solutions through worksite clinics serving employees.

Additional information about Northwind Pharmaceuticals can be found at www.nwpharma.com.

For further information contact:

Haley Williams, 317.846.8965 (office), haley@bpsind.com

Schedule a free claims analysis now.

Let’s Talk now

New Drugs to Market – October Update

Phillip Berry | Oct 25th, 2024
The Food and Drug Administration (FDA) approved three novel drug therapies in October. One of those therapies,  Hympavzi (marstacimab-hncq), is a medication indicated for the treatment of patients with Hemophilia A and Hemophilia B. Hympavzi utilizes a new pathway to help reduce the risk of bleeding episodes in patients with Hemophilia, a disease that impacts … more »

continue reading

Letter From a Pharmacist – On Pharmacy Closures

Phillip Berry | Oct 25th, 2024
Pharmacists have a time-honored role as an integral contributor to the delivery of health care. From the earliest apothecaries to the retail stores of today, community pharmacists have provided guidance about health, wellness and medication therapy. Their expertise ranges from preventive care to the most advanced medications used in the treatment of complex disease.  Despite … more »

continue reading

Stewardship and the Beauty of Health Benefits

Phillip Berry | Oct 25th, 2024
The Beauty of Making a Difference Beauty in health benefits? What does that even mean? Think back on your experience as an HR/benefits professional. What are the peak moments? Most would agree that the high points are moments when they see their work directly impacting an employee or plan member. A time when the health … more »

continue reading